Darren Bondar, president and CEO of Inner Spirit Holdings (CSE:ISH), believes when it comes to signing deals with license holders for retail locations, companies still need to answer to investors and find proper returns for these transactions.

Bondar spoke with the Investing News Network (INN) during the MJBizConINT’L event in Toronto. At the show he also participated in a panel discussion on lessons learned from the first year of adult-use legalization in Canada from the perspective of retailers.

The executive told INN he is hopeful the Ontario market will move forward with an open system for retail stores. During the panel, the cannabis executive said Ontario could “easily hold 1,000 stores without looking like the pot capital of the world.”

Ontario has proven to be one of the most complex markets for marijuana retailers. The province elected to introduce a lottery system to grant options to earn a store license. This year two lotteries have taken place, with the second round expected to result in new stores in October.

A variety of publicly traded marijuana companies have pursued deals with lottery winners. These deals grant companies a chance to participate in the opening and maintenance of actual stores.

In August, Inner Spirit, through its retail brand Spiritleaf, announced deals with two lottery winners for stores in the East and Greater Toronto Area regions of Ontario, as designated by the Alcohol and Gaming Commission of Ontario.

“These lottery winners were seeking a strong partner to work with, so we are very pleased Spiritleaf has been selected to help them establish and operate their stores,” Bondar said in a statement.

Bondar told INN that dealing with slow regulations has been a difficult process for fellow retail operator companies, with many having to retain leases on planned shops for months.

In a previous interview with INN, Matthew Pallotta, equity research analyst at Echelon Wealth Partners covering the multi-state operator market in the US, said in his estimation the lack of retail access to consumers, due to a slow roll out, is one of, if not the biggest, detriments to the Canadian market since adult-use legalization.

Bondar hopes the opening of the Ontario market will pave the way to easing this issue across the country.

Watch the interview above to hear the rest of Bondar’s comments from the cannabis event.

Don’t forget to look for the rest of our coverage of MJBizConINT’L, with exclusive interviews and more insights from the show. You can also follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less